These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 26025192)

  • 1. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease.
    Lee BT; Ahmed FA; Hamm LL; Teran FJ; Chen CS; Liu Y; Shah K; Rifai N; Batuman V; Simon EE; He J; Chen J
    BMC Nephrol; 2015 May; 16():77. PubMed ID: 26025192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not all inflammatory markers are linked to kidney function: results from a population-based study.
    Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
    Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.
    Gupta J; Mitra N; Kanetsky PA; Devaney J; Wing MR; Reilly M; Shah VO; Balakrishnan VS; Guzman NJ; Girndt M; Periera BG; Feldman HI; Kusek JW; Joffe MM; Raj DS;
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):1938-46. PubMed ID: 23024164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and Progression of CKD: The CRIC Study.
    Amdur RL; Feldman HI; Gupta J; Yang W; Kanetsky P; Shlipak M; Rahman M; Lash JP; Townsend RR; Ojo A; Roy-Chaudhury A; Go AS; Joffe M; He J; Balakrishnan VS; Kimmel PL; Kusek JW; Raj DS;
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1546-1556. PubMed ID: 27340285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients.
    Spoto B; Leonardis D; Parlongo RM; Pizzini P; Pisano A; Cutrupi S; Testa A; Tripepi G; Zoccali C; Mallamaci F
    Nutr Metab Cardiovasc Dis; 2012 Nov; 22(11):981-8. PubMed ID: 21906921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraindividual interleukin-6 variations on the cardiovascular prognosis of patients with chronic renal disease.
    Goicoechea M; Quiroga B; García de Vinuesa S; Verdalles U; Reque J; Panizo N; Arroyo D; Santos A; Macías N; Luño J
    Ren Fail; 2012; 34(8):1002-9. PubMed ID: 22746155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.
    Kaminski TW; Pawlak K; Karbowska M; Znorko B; Mor AL; Mysliwiec M; Pawlak D
    Int Urol Nephrol; 2019 Mar; 51(3):491-502. PubMed ID: 30617956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atorvastatin on biomarkers of inflammation in chronic kidney disease.
    Fassett RG; Robertson IK; Ball MJ; Geraghty DP; Coombes JS
    Clin Nephrol; 2014 Feb; 81(2):75-85. PubMed ID: 24321183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease.
    Dounousi E; Koliousi E; Papagianni A; Ioannou K; Zikou X; Katopodis K; Kelesidis A; Tsakiris D; Siamopoulos KC
    Am J Nephrol; 2012; 36(6):531-6. PubMed ID: 23258075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and oxidation: do they improve after kidney transplantation? Relationship with mortality after transplantation.
    Cañas L; Iglesias E; Pastor MC; Barallat J; Juega J; Bancu I; Lauzurica R
    Int Urol Nephrol; 2017 Mar; 49(3):533-540. PubMed ID: 28013471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.
    Amdur RL; Feldman HI; Dominic EA; Anderson AH; Beddhu S; Rahman M; Wolf M; Reilly M; Ojo A; Townsend RR; Go AS; He J; Xie D; Thompson S; Budoff M; Kasner S; Kimmel PL; Kusek JW; Raj DS;
    Am J Kidney Dis; 2019 Mar; 73(3):344-353. PubMed ID: 30545708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study.
    Fox ER; Benjamin EJ; Sarpong DF; Nagarajarao H; Taylor JK; Steffes MW; Salahudeen AK; Flessner MF; Akylbekova EL; Fox CS; Garrison RJ; Taylor HA
    BMC Nephrol; 2010 Jan; 11():1. PubMed ID: 20078870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD.
    Schei J; Stefansson VT; Mathisen UD; Eriksen BO; Solbu MD; Jenssen TG; Melsom T
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):280-6. PubMed ID: 26668020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
    Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum lncRNA H19 expression with inflammatory and oxidative stress markers and routine biochemical parameters in chronic kidney disease.
    Okuyan HM; Dogan S; Terzi MY; Begen MA; Turgut FH
    Clin Exp Nephrol; 2021 May; 25(5):522-530. PubMed ID: 33548016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between C-reactive protein levels and the risk for chronic kidney disease hospitalizations in adults of a remote Indigenous Australian community - A prospective cohort study.
    Arnold LW; Hoy WE; Wang Z
    Nephrology (Carlton); 2017 Sep; 22(9):699-705. PubMed ID: 27312245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease.
    Dai L; Watanabe M; Qureshi AR; Mukai H; Machowska A; Heimbürger O; Barany P; Lindholm B; Stenvinkel P
    Eur J Intern Med; 2019 Oct; 68():60-65. PubMed ID: 31402276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
    Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
    Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.
    Chen J; Bundy JD; Hamm LL; Hsu CY; Lash J; Miller ER; Thomas G; Cohen DL; Weir MR; Raj DS; Chen HY; Xie D; Rao P; Wright JT; Rahman M; He J
    Hypertension; 2019 Apr; 73(4):785-793. PubMed ID: 30776971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Markers and Outcomes in Kidney Transplant Recipients.
    Molnar MZ; Nagy K; Remport A; Tapolyai MB; Fülöp T; Kamal F; Kovesdy CP; Mucsi I; Mathe Z
    Transplantation; 2017 Sep; 101(9):2152-2164. PubMed ID: 27798514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.